Addleshaw Goddard is pleased to announce the appointment of Gary Howes as Director of Life Sciences, marking a significant expansion of the firm's capabilities in this critical sector.

Gary joins Addleshaw Goddard from McDermott Will & Emery, where he has established himself as a leading specialist in Life Sciences, with particular expertise in life sciences transactions, with a focus on patent licences and collaborations, complex contracts, and product portfolio deals, as well as IP and regulatory advisory work, catering to a diverse range of clients from both private and public sectors.

Recognised for his profound industry knowledge, Gary has been named in the European Counsel Life Science's Industry Report 'Super League for Intellectual Property' and has been 'highly recommended' by Global Counsel for his patent expertise, commercial IP, and protection issues. He is consistently recommended in the Legal 500 and Chambers UK, where he is praised for his exceptional ability in commercial agreements and his skill in making complex legal issues accessible to non-specialists.

Michael O'Connor, Co-Head of Healthcare & Life Sciences said, "We are absolutely delighted that Gary has chosen to join us to continue to build our global life sciences practice. Gary will help us provide our clients who operate in the life sciences sector with insightful advice grounded in 35 years of experience and will help us build a leading LS business in the near future."

Gary's appointment is a testament to AG's commitment in strengthening its capabilities in the Life Sciences sector and providing a specialist full service offering to all clients.

The firm's Life Sciences team now comprises of 30 lawyers across all offices.